These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2923578)

  • 41. Fate of milk 125I-labelled lipoprotein lipase in cells in culture. Comparison of lipoprotein lipase- and non-lipoprotein lipase-synthesizing cells.
    Friedman G; Chajek-Shaul T; Olivecrona T; Stein O; Stein Y
    Biochim Biophys Acta; 1982 Apr; 711(1):114-22. PubMed ID: 7066365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein lipase and uptake of triacylglycerol, cholesterol and phosphatidylcholine from chylomicrons by mammary and adipose tissue of lactating rats in vivo.
    Scow RO; Chernick SS; Fleck TR
    Biochim Biophys Acta; 1977 May; 487(2):297-306. PubMed ID: 861238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the metabolism of chylomicrons and chylomicron remnants by the perfused liver.
    Gardner RS; Mayes PA
    Biochem J; 1978 Jan; 170(1):47-55. PubMed ID: 629782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
    Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
    Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chylomicron margination, lipolysis, and vitamin a uptake in the lactating rat mammary gland: implications for milk retinoid content.
    Ross AC; Pasatiempo AM; Green MH
    Exp Biol Med (Maywood); 2004 Jan; 229(1):46-55. PubMed ID: 14709776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.
    Choi SY; Fong LG; Kirven MJ; Cooper AD
    J Clin Invest; 1991 Oct; 88(4):1173-81. PubMed ID: 1918372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholesterol content as a possible determinant in the removal of chylomicron triglyceride by the liver.
    Vessby B; Ontko JA
    Atherosclerosis; 1983 May; 47(2):111-22. PubMed ID: 6870994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic retention and elimination of cholesteryl linoleyl ether after injection of labeled acetylated LDL or chylomicrons.
    Stein Y; Kleinman Y; Halperin G; Stein O
    Biochim Biophys Acta; 1983 Feb; 750(2):300-5. PubMed ID: 6860683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipoprotein lipase and hepatic lipase deficiencies associated with impaired chylomicron clearance in D-(+) galactosamine hepatitis.
    Black DD; Freeman MR; Sabesin SM
    Metabolism; 1982 Jun; 31(6):620-6. PubMed ID: 7078435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clearance from plasma of lymph chylomicrons and chylomicron remnants labelled with 125I-tyramine-cellobiose.
    Ly HL; Mortimer BC; Baker E; Redgrave TG
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):937-43. PubMed ID: 1417753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydrolysis of chylomicron triacylglycerol by endothelium-bound lipoprotein lipase. Effect of decreased apoprotein C-II/C-III ratio.
    Kotlar TJ; Borensztajn J
    Biochem J; 1979 Oct; 183(1):171-4. PubMed ID: 534481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The uptake and metabolism of chylomicron-remnant lipids by rat liver parenchymal and non-parenchymal cells in vitro.
    Lippiello PM; Sisson PJ; Waite M
    Biochem J; 1985 Dec; 232(2):395-401. PubMed ID: 4091796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Composition, removal and metabolic fate of chylomicrons derived from diabetic rats.
    Levy E; Shafrir E; Ziv E; Bar-On H
    Biochim Biophys Acta; 1985 May; 834(3):376-85. PubMed ID: 3995073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats.
    Sultan F; Lagrange D; Jansen H; Griglio S
    Biochim Biophys Acta; 1990 Jan; 1042(1):150-2. PubMed ID: 2297520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormonal mediation of rat heart lipoprotein lipase activity after fat feeding.
    Pedersen ME; Wolf LE; Schotz MC
    Biochim Biophys Acta; 1981 Oct; 666(1):191-7. PubMed ID: 6271234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase.
    Sultan F; Lagrange D; Le Liepvre X; Griglio S
    Biochem J; 1989 Mar; 258(2):587-94. PubMed ID: 2706002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrolysis of chylomicron phosphatidylcholine in vitro by lipoprotein lipase, phospholipase A2 and phospholipase C.
    Scow RO; Egelrud T
    Biochim Biophys Acta; 1976 Jun; 431(3):538-49. PubMed ID: 949490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pathogenesis of neurogenic hypercholesterolemia. IV. Abnormal metabolism of chylomicronous cholesterol.
    Friedman M; Byers SO; Elek S
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):359-64. PubMed ID: 4683259
    [No Abstract]   [Full Text] [Related]  

  • 60. Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.
    Windler EE; Greeve J; Daerr WH; Greten H
    Biochem J; 1988 Jun; 252(2):553-61. PubMed ID: 3415673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.